SARA COOKE: Open Payments
NPI 1174119820 · SEBRING, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,145 in 96 payments from 37 companies in 2025. Trend: 2023 $2,646 · 2024 $3,720 · 2025 $2,145
Food & beverage: $2,145
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $341 |
| Novartis Pharmaceuticals Corporation | 9 | $193 |
| Daiichi Sankyo Inc. | 6 | $169 |
| AstraZeneca Pharmaceuticals LP | 7 | $148 |
| ABBVIE INC. | 5 | $129 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $96 |
| Merck Sharp & Dohme LLC | 3 | $82 |
| Stemline Therapeutics Inc. | 3 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $74 |
| Iovance Biotherapeutics, Inc. | 2 | $51 |
Products named: RYBREVANT, Enhertu, KEYTRUDA, TECVAYLI, Orserdu, IMFINZI, Nubeqa, FRUZAQLA.
Industry payments across FL — which companies pay providers there.
